Ambio will test ibogaine, an experimental, naturally occurring psychedelic, as a therapy for neurodegenerative conditions ...

Helius Medical Technologies calls the out-of-network reimbursement the first step in making the PoNS device more accessible to MS patients.

Enrollment is now complete in two Phase 3 clinical trials testing vidofludimus calcium in adults with relapsing forms of ...

If a routine streamlined a process and passed the common sense test, I was more than happy to adopt it. However, if it caused ...

Dr. Susan Payrovi and Dr. Mirla Avila have an in-depth discussion around treating MS, and considerations when selecting an MS treatment.

Task-oriented training may help balance issues for people with MS, but current evidence is inconsistent, a study found.

Four Canadian nurses are among the 11 recipients of this year's International Nightingale Awards, which support innovative ...

Infections and stressful life events in childhood may increase the risk of developing MS, according to a study.

A study of 125 children with POMS and 145 without major health disorders found that epigenetic age tended to be higher in children with POMS.

Ocrevus appears to be a safe and effective treatment for children and adolescents with MS, according to real-world data from ...

Body mass index (BMI) does not seem to affect responses to stem cell transplant in people with MS, a study found.

MS prevalence has increased by about one-third in New Zealand in recent decades, though some barriers to diagnosis still ...